J. Isabelle Choi, MD, FACRO

Undergraduate
Harvard University
Medical School
University of Texas Health Science Center School of Medicine
Residency
Kaiser Permanente Los Angeles Medical Center (Chief Resident)

Radiation Oncology

Dr. Choi’s research focuses on improving outcomes, reducing toxicities and more effectively delivering radiotherapy for breast cancer and gastrointestinal malignancies. As NYPC’s Director of Research, she oversees 22 clinical trials across numerous types of cancers. She is the principal investigator of numerous clinical trials at NYPC, including:
* Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early-Stage Breast Cancer
* A Randomized Phase III Trial Evaluating the Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
* Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer
* Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Among her select national leadership appointments, Dr. Choi is Chair of the Proton Collaborative Group (PCG) Publications Committee, Chair of the PCG Breast Subcommittee, Chair of the National Association of Proton Therapy’s Physician Advisory Committee, and President of the Korean American Society of Radiation Oncology.